Frequency and severity of irritable bowel syndrome in cigarette smokers, Turkey 2019

Cigarette smoking has recently been associated with several gastrointestinal symptoms, and smoking cessation has been recommended as a lifestyle change strategy for irritable bowel syndrome (IBS). This study assessed the prevalence of IBS in cigarette smokers based on the Rome IV criteria, the sever...

Full description

Saved in:
Bibliographic Details
Published in:Tobacco induced diseases 2022-03, Vol.20 (March), p.27-8
Main Authors: Başpınar, Melike Mercan, Basat, Okcan
Format: Article
Language:English
Subjects:
Abdomen
Age
Cigarette smoking
Cigarettes
Constipation
Criteria
Defecation
Dependence
Diarrhea
Drug addiction
Drug dependence
Education
Family medical history
Gastrointestinal symptoms
Intestine
Irritable bowel syndrome
Nicotine
nicotine dependence
Pain
Patients
Regression analysis
Research Paper
rome iv criteria
Sex
Smoking
Smoking cessation
Statistical analysis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cigarette smoking has recently been associated with several gastrointestinal symptoms, and smoking cessation has been recommended as a lifestyle change strategy for irritable bowel syndrome (IBS). This study assessed the prevalence of IBS in cigarette smokers based on the Rome IV criteria, the severity of nicotine dependence, and the effect of smoking cessation in smokers with IBS. This prospective study included 371 smokers who attended smoking cessation treatment at family medicine clinics in a tertiary hospital between January and April 2019, in Turkey. Data on demographic characteristics, IBS status according to the Rome IV criteria, and Fagerström test for nicotine dependence (FTND) scores were collected during face-to-face interviews. The mean patient age was 40.7 ± 11.96 years. Out of the total patients, 29.4% were heavy smokers, and 18.1% had IBS. There was a significant difference in age (p=0.03), duration of smoking (p=0.05), FTND score (p=0.02), and sex (p
ISSN:1617-9625
2070-7266
1617-9625
DOI:10.18332/tid/145925